Following a month-long inspection in August, the FDA reprimanded Catalent for numerous quality lapses observed at its Bloomington, Ind., plant — where the drugmaker has performed manufacturing activities for both Moderna’s and Johnson & Johnson’s COVID-19 vaccines.
Source: Drug Industry Daily